Press release
November 6, 2026
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arcutis Biotherapeutics, Inc. (ARQT)
We couldn't retrieve the full text for this release. Read it on the company's site.